Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer. Issue 7 (July 2015)

• Record Type: Journal Article
• Authors: Strom, Tobin J.; Trotti, Andy M.; Kish, Julie; Russell, Jeffery S.; Rao, Nikhil G.; McCaffrey, Judith; Padhya, Tapan A.; Otto, Kristen J.; Caudell, Jimmy J.
• Is Part Of: Oral oncology. Volume 51:Issue 7(2015:Jul.)
• Page Start: 704
• Page End: 708
• Publication Date: 2015-07
• Subjects: Mouth -- Cancer -- Periodicals; Mouth -- Tumors -- Periodicals; Mouth Diseases -- Periodicals; Mouth Neoplasms -- Periodicals; Bouche -- Cancer -- Périodiques; Bouche -- Tumeurs -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9943105
• DOI: 10.1016/j.oraloncology.2015.04.012
• Languages: English
• ISSNs: 1368-8375

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st005">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0005">We compared outcomes with concurrent cisplatin and cetuximab and RT in LAHNC patients.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0010">There was no difference in locoregional control or survival between the groups.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0015">There was also found no difference in dysphagia toxicity between the groups.</p> </list-item> <list-item id="o0020"> <label></label> <p id="p0020">Both therapies are reasonable treatments until prospective data is available.</p> </list-item> </list> </p> </sec> </abstract>